304 related articles for article (PubMed ID: 8432350)
21. Nerve growth factor-induced sprouting of mature, uninjured sympathetic axons.
Isaacson LG; Saffran BN; Crutcher KA
J Comp Neurol; 1992 Dec; 326(3):327-36. PubMed ID: 1469116
[TBL] [Abstract][Full Text] [Related]
22. Axotomized septal cholinergic neurons rescued by nerve growth factor or neurotrophin-4/5 fail to express the inducible transcription factor c-Jun.
Hughes PE; Alexi T; Hefti F; Knusel B
Neuroscience; 1997 Jun; 78(4):1037-49. PubMed ID: 9174072
[TBL] [Abstract][Full Text] [Related]
23. Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor.
Williams LR; Inouye G; Cummins V; Pelleymounter MA
J Pharmacol Exp Ther; 1996 May; 277(2):1140-51. PubMed ID: 8627526
[TBL] [Abstract][Full Text] [Related]
24. Nerve growth factor induces a dose-dependent and long-lasting increase of choline acetyltransferase activity in the septal area and hippocampus of uninjured rats.
Vantini G; Fusco M; Schiavo N; Gradkowska M; Zaremba M; Leon A; Oderfeld-Nowak B
Acta Neurobiol Exp (Wars); 1990; 50(4-5):323-31. PubMed ID: 2130652
[TBL] [Abstract][Full Text] [Related]
25. Evidence for sprouting specificity following medial septal lesions in the rat.
Crutcher KA; Chandler JP
J Comp Neurol; 1985 Jul; 237(1):116-26. PubMed ID: 4044889
[TBL] [Abstract][Full Text] [Related]
26. Effects of exogenous nerve growth factor upon sympathetic sprouting into the hippocampal formation.
Conner JM; Varon S
Exp Neurol; 1995 Dec; 136(2):123-35. PubMed ID: 7498402
[TBL] [Abstract][Full Text] [Related]
27. Dose-dependent responses to nerve growth factor by adult rat cholinergic medial septum and neostriatum neurons.
Vahlsing HL; Hagg T; Spencer M; Conner JM; Manthorpe M; Varon S
Brain Res; 1991 Jun; 552(2):320-9. PubMed ID: 1655171
[TBL] [Abstract][Full Text] [Related]
28. Long-term administration of mouse nerve growth factor to adult rats with partial lesions of the cholinergic septohippocampal pathway.
Junard EO; Montero CN; Hefti F
Exp Neurol; 1990 Oct; 110(1):25-38. PubMed ID: 2170164
[TBL] [Abstract][Full Text] [Related]
29. Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment.
Montero CN; Hefti F
J Neurosci; 1988 Aug; 8(8):2986-99. PubMed ID: 2842469
[TBL] [Abstract][Full Text] [Related]
30. Sympathetic response to intracranial NGF infusion in the absence of afferent input: axonal sprouting without neurotransmitter production.
Isaacson LG; Schwenk KL; Billieu SC; Crutcher KA
Exp Neurol; 1996 Sep; 141(1):57-66. PubMed ID: 8797668
[TBL] [Abstract][Full Text] [Related]
31. Recovery of ChAT immunoreactivity in axotomized rat cholinergic septal neurons despite reduced NGF receptor expression.
Naumann T; Straube A; Frotscher M
Eur J Neurosci; 1997 Jul; 9(7):1340-9. PubMed ID: 9240391
[TBL] [Abstract][Full Text] [Related]
32. Loss of AChE- and NGFr-labeling precedes neuronal death of axotomized septal-diagonal band neurons: reversal by intraventricular NGF infusion.
Fischer W; Björklund A
Exp Neurol; 1991 Aug; 113(2):93-108. PubMed ID: 1868909
[TBL] [Abstract][Full Text] [Related]
33. In vivo evidence for a hippocampal adrenergic neuronotrophic factor specifically released on septal deafferentation.
Björklund A; Stenevi U
Brain Res; 1981 Dec; 229(2):403-28. PubMed ID: 7306819
[TBL] [Abstract][Full Text] [Related]
34. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons.
Emerich DF; Winn SR; Harper J; Hammang JP; Baetge EE; Kordower JH
J Comp Neurol; 1994 Nov; 349(1):148-64. PubMed ID: 7852623
[TBL] [Abstract][Full Text] [Related]
35. Nerve growth factor prevents apoptotic cell death in injured central cholinergic neurons.
Wilcox BJ; Applegate MD; Portera-Cailliau C; Koliatsos VE
J Comp Neurol; 1995 Sep; 359(4):573-85. PubMed ID: 7499548
[TBL] [Abstract][Full Text] [Related]
36. Intraventricular nerve growth factor administration prevents lesion-induced loss of septal cholinergic neurons in aging rats.
Montero CN; Hefti F
Neurobiol Aging; 1989; 10(6):739-43. PubMed ID: 2628784
[TBL] [Abstract][Full Text] [Related]
37. Nerve growth factor (NGF) reverses axotomy-induced decreases in choline acetyltransferase, NGF receptor and size of medial septum cholinergic neurons.
Hagg T; Fass-Holmes B; Vahlsing HL; Manthorpe M; Conner JM; Varon S
Brain Res; 1989 Dec; 505(1):29-38. PubMed ID: 2558781
[TBL] [Abstract][Full Text] [Related]
38. Reversibility of nerve growth factor's enhancement of choline acetyltransferase activity in cultured embryonic rat septum.
Nonner D; Brass BJ; Barrett EF; Barrett JN
Exp Neurol; 1993 Aug; 122(2):196-208. PubMed ID: 8405259
[TBL] [Abstract][Full Text] [Related]
39. Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF.
Strömberg I; Wetmore CJ; Ebendal T; Ernfors P; Persson H; Olson L
J Neurosci Res; 1990 Mar; 25(3):405-11. PubMed ID: 2325166
[TBL] [Abstract][Full Text] [Related]
40. Trophic effect of exogenous nerve growth factor on rat striatal cholinergic neurons: comparison between intraparenchymal and intraventricular administration.
Venero JL; Hefti F; Knusel B
Mol Pharmacol; 1996 Feb; 49(2):303-10. PubMed ID: 8632763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
